The Indian pharma market grew just 2.4% in June compared to last year.
That’s because fewer patients visited doctors and hospitals during the lockdown.
But pharma companies are finding new opportunities.
Piramal Pharma.
One of India’s largest pharmaceutical companies, has adapted to changing demands during the pandemic.
It is also betting on fresh funds from the US-based private equity firm Carlyle that has agreed to acquire a 20% stake in the company for about $490 million.
Nandini Piramal, ED, Piramal Enterprises spearheaded the negotiations and talks to the BBC’s Devina Gupta about their next bets in the sector.